Skip to main navigation Skip to search Skip to main content

Weekly: VistaGen Therapeutics (VTGN: $1.68) slides 7.2% on weak volume; -13c [7.2%]

Press/Media

Period7 Aug 2023

Media coverage

1

Media coverage